4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 02-2021 | 12-2020 | 02-2020 | 12-2019 | |
| Sales | 718 | 690 | 690 | 0 | 269 |
| Gross Profit | 718 | 690 | 690 | N/A | 269 |
| Operating Expenses | 37,979 | 35,700 | 35,700 | 0 | 40,530 |
| Operating Income | -37,261 | -35,010 | -35,010 | N/A | -40,261 |
| Interest Expense | 581 | 0 | 0 | 0 | 0 |
| Other Income | 5,882 | 4,496 | 4,502 | 0 | 9,928 |
| Pre-tax Income | -31,960 | -30,514 | -30,508 | 0 | -30,333 |
| Income Tax | -22 | -13 | -13 | N/A | N/A |
| Net Income Continuous | -31,938 | -30,501 | -30,495 | N/A | -30,333 |
| Net Income | $-31,938 | $-30,501 | $-30,495 | $N/A | $-30,333 |
| EPS Basic Total Ops | -1.52 | N/A | -2.16 | N/A | -0.46 |
| EPS Basic Continuous Ops | -1.51 | N/A | -2.14 | N/A | -0.46 |
| EPS Diluted Total Ops | -1.52 | N/A | -2.16 | N/A | -0.46 |
| EPS Diluted Continuous Ops | -1.51 | N/A | -2.14 | N/A | -0.46 |
| EPS Diluted Before Non-Recurring Items | -1.52 | N/A | -2.34 | -0.50 | -4.17 |
| EBITDA(a) | $-35,789 | $-33,438 | $-33,438 | $N/A | $-38,617 |